Vernacare, a leading infection control organisation, has been sold to Palatine Private Equity. Clearwater International advised the shareholders on the sale.
Based in Bolton, Vernacare employs over 200 staff across the UK and North America and sells to a varied customer base in more than 50 countries worldwide.
The company manufactures and supplies a range of products including the Vernacare system, which is the most widely adopted single-use disposable system in the UK healthcare market. It is comprised of moulded fibre containers used for toileting, washing, bathing and caring for patients throughout their stay, in addition to Vortex disposal units that hygienically dispose of the containers and contents.
Vernacare is the market leader in the UK, supplying to 260 NHS Hospital Trusts, and has an established presence in the rest of Europe, Canada, Australia, and the Far East. The company is currently pursuing further international growth opportunities and has recently signed an agreement with a leading healthcare provider in China as part of the Chancellor’s recent trade visit.
The deal sees Palatine take a majority share in Vernacare. The firm will work with the management team which is led by CEO Matt Miller and CFO Paul Wright.
Clearwater International managing partner Phil Burns, directors Ramesh Jassal and Nick Horrocks and associate director Chiara Pettinicchio advised the Vernacare shareholders on the sale.